Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.3% sodium hyaluronate ophthalmic solution for dry eye
ChiCTR-OPC-15007197Phase 4Recruiting
- Sponsor
- Eye Institute of Xiamen University
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium hyaluronate in dry eye syndrome (DED), sponsored by Eye Institute of Xiamen University. Primary endpoints: tear meniscus height, tear film break-up time and 1 more. Started Jun 2015; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR-OPC-15007197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15007197.